Mass production of low-cost antiretrovirals (ARVs) has already allowed over 17 million individuals to access treatment for HIV infection. mainly in low-income countries. It is possible to manufacture combination ARVs for $110 per person-year. using tenofovir (TDF). https://www.hacklinkci.com/